William Brondyk

William Brondyk is the Chief Scientific Officer at Invetx. His role is to develop and execute a research strategy to generate innovative and transformative biotherapeutics for the Animal Health market. William has more than 20 years of experience in developing protein therapeutics for oncology indications, immune-mediated diseases, infectious diseases, rare diseases, and reproductive health and contraception.

William received his Ph.D. in Oncology from the University of Wisconsin-Madison.